Document:

2014.12.13 CMRX EX 10.17

June 13, 2014
		
	Re:
	Member of the Board of Directors of Chimerix, Inc.

Dear Catherine:
It is my sincere pleasure, on behalf of Chimerix, Inc. (“Chimerix”), to offer you a position as a member of the Board of Directors (the “Board”) of Chimerix, contingent and effective upon your formal approval by the Board at a meeting to take place on June 20, 2014 and your acceptance of the terms of this offer.  
As compensation for your service as a member of the Board, you will receive a $35,000 annual retainer.  You will also be granted a nonqualified stock option to purchase 18,000 shares of common stock pursuant to our 2013 Equity Incentive Plan (the “Plan”), at an exercise price equal to the closing price of Chimerix’s common stock on the date of grant, which would occur on the later of June 20, 2014 and your acceptance of this offer.  One-fourth of the shares subject to this option will vest on the one year anniversary of the date of grant and the balance of the shares will vest in a series of 36 equal monthly installments thereafter, such that the option will be fully vested on the fourth anniversary of the date of grant, subject to your continued service.   
With your continued service on the Board you will be compensated in accordance with the terms of the Chimerix, Inc. Non-Employee Director Compensation Policy.  Chimerix will also reimburse you for reasonable out-of-pocket travel expenses incurred in connection with your attendance at Board meetings.
If the terms of this letter are acceptable to you and you agree to serve as a member of the Board if appointed, please sign and date this letter below and return it to us via PDF, retaining a copy for your records.
Very truly yours,
/s/ M. Michelle Berrey
M. Michelle Berrey
President, Chief Executive Officer and Chief Medical Officer
Chimerix, Inc.

Accepted and agreed:

  /s/ Catherine Gilliss    
Catherine L. Gilliss

Date:      6/16/142014.12.31 CMRX EX 10.18

May 30, 2014
		
	Re:
	Member of the Board of Directors of Chimerix, Inc.

Dear Patrick:
It is my sincere pleasure, on behalf of Chimerix, Inc. (“Chimerix”), to offer you a position as a member of the Board of Directors (the “Board”) of Chimerix, contingent and effective upon your formal approval by the Board at a meeting to take place on June 20, 2014 and your acceptance of the terms of this offer.  It is also anticipated that the Board will appoint you as a member of the Audit Committee of the Board.
As compensation for your service as a member of the Board, you will receive a $35,000 annual retainer, and as compensation for your service as a member of the Audit Committee, you will receive an $7,500 annual retainer.  You will also be granted a nonqualified stock option to purchase 18,000 shares of common stock pursuant to our 2013 Equity Incentive Plan (the “Plan”), at an exercise price equal to the closing price of Chimerix’s common stock on the date of grant, which would occur on the later of June 20, 2014 and your acceptance of this offer.  One-fourth of the shares subject to this option will vest on the one year anniversary of the date of grant and the balance of the shares will vest in a series of 36 equal monthly installments thereafter, such that the option will be fully vested on the fourth anniversary of the date of grant, subject to your continued service.   
With your continued service on the Board you will be compensated in accordance with the terms of the Chimerix, Inc. Non-Employee Director Compensation Policy.  Chimerix will also reimburse you for reasonable out-of-pocket travel expenses incurred in connection with your attendance at Board meetings.
If the terms of this letter are acceptable to you and you agree to serve as a member of the Board if appointed, please sign and date this letter below and return it to us via PDF, retaining a copy for your records.
Very truly yours,
/s/ M. Michelle Berrey
M. Michelle Berrey
President, Chief Executive Officer and Chief Medical Officer
Chimerix, Inc.

Accepted and agreed:

 /s/ C. Patrick Machado    
Patrick Machado 

Date:      6/1/20142014.12.13 CMRX EX 10.19

December 12, 2014
		
	Re:
	Member of the Board of Directors of Chimerix, Inc.

Dear Ron:
It is my sincere pleasure, on behalf of Chimerix, Inc. (“Chimerix”), to offer you a position as a member of the Board of Directors (the “Board”) of Chimerix, contingent and effective upon your formal approval by the Board at a meeting to take place on December 17, 2014 and your acceptance of the terms of this offer.  
As compensation for your service as a member of the Board, you will receive a $35,000 annual retainer.  You will also be granted a nonqualified stock option to purchase 18,000 shares of common stock pursuant to our 2013 Equity Incentive Plan (the “Plan”), at an exercise price equal to the closing price of Chimerix’s common stock on the date of grant, which would occur on the later of December 17, 2014 and your acceptance of this offer.  One-fourth of the shares subject to this option will vest on the one year anniversary of the date of grant and the balance of the shares will vest in a series of 36 equal monthly installments thereafter, such that the option will be fully vested on the fourth anniversary of the date of grant, subject to your continued service.   
With your continued service on the Board you will be compensated in accordance with the terms of the Chimerix, Inc. Non-Employee Director Compensation Policy.  Chimerix will also reimburse you for reasonable out-of-pocket travel expenses incurred in connection with your attendance at Board meetings.
If the terms of this letter are acceptable to you and you agree to serve as a member of the Board if appointed, please sign and date this letter below and return it to us via PDF, retaining a copy for your records.
Very truly yours,
/s/ M. Michelle Berrey
M. Michelle Berrey, M.D., M.P.H.
President and Chief Executive Officer
Chimerix, Inc.

Accepted and agreed:

/s/ Ronald C. Renaud, Jr.    
Ronald C. Renaud, Jr.

Date:      12/15/20142014.12.31 CMRX EX 10.29

	
															
	AMENDMENT OF SOLICITATION/MODIFICATION OF CONTRACT
	1.   CONTRACT ID CODE
	 PAGE   OF   PAGES

	1
	2
	 

	2.  AMENDMENT/MODIFICATION NO.
	3.  EFFECTIVE DATE
	4.  REQUISITION/PURCHASE REQ. NO.
	 5.  PROJECT NO. (if applicable)

	18
	See Block 16C
	N/A.
	 

	6.  ISSUED BY
	CODE
	ASPR-BARDA
	7.  ADMINISTERED BY (If other than Item 6)

	CODE
	ASPR-BARDA02

	ASPR-BARDA
200 Independence Ave., S.W.
Room 640-G
Washington DC 20201

	ASPR-BARDA
330 Independence Ave, SW, Rm G640
Washington DC 20201

	8.  NAME AND ADDRESS OF CONTRACTOR (No., street, county, State and ZIP Code)
	(x)
	9A.  AMENDMENT OF SOLICITATION NO.

	

CHIMERIX, INC. 1377270
CHIMERIX, INC.   2505 MERIDIAN P
2505 MERIDIAN PKWY  STE 340
DURHAM NC  277135246
	 
	 

	 9B.  DATED (SEE ITEM 11)

	 
	 

	x
	 10A.  MODIFICATION OF CONTRACT/ORDER NO.
 HHSO100201100013C

	 
	 

	 10B.  DATED (SEE ITEM 13)
02/16/2011

	CODE 
1377270
	FACILITY CODE   
	 

	11.  THIS ITEM ONLY APPLIES TO AMENDMENTS OF SOLICITATIONS

	o   The above numbered solicitation is amended as set forth in Item 14. The hour and date specified for receipt of Offers   o  is extended.    o is not extended
Offers must acknowledge receipt of this amendment prior to the hour and date specified in the solicitation or as amended, by one of the following methods: (a) By completing Items 8 and 15, and returning ___________ copies of the amendment; (b) By acknowledging receipt of this amendment on each copy of the offer submitted; or (c) By separate letter or telegram which includes a reference to the solicitation and amendment numbers.  FAILURE OF YOUR ACKNOWLEDGEMENT TO BE RECEIVED AT  
THE PLACE DESIGNATED FOR THE RECEIPT OF OFFERS PRIOR TO THE HOUR AND DATE SPECIFIED MAY RESULT IN REJECTION OF YOUR OFFER. If by  
virtue of this amendment you desire to change an offer already submitted, such change may be made by telegram or letter, provided each telegram or letter makes  
reference to the solicitation and this amendment, and is received prior to the opening hour and date specified.

	12.  ACCOUNTING AND APPROPRIATION DATA (if required)
N/A

	13.  THIS ITEM ONLY APPLIES TO MODIFICATION OF CONTRACTS/ORDERS. IT MODIFIES THE CONTRACT/ORDER NO. AS DESCRIBED IN ITEM 14.

	CHECK ONE
	A.   THIS CHANGE ORDER IS ISSUED PURSUANT TO:  (Specify authority)  THE CHANGES SET FORTH IN ITEM 14 ARE MADE IN THE CONTRACT ORDER NO. IN ITEM 10A.

	 

	

X
	B.   THE ABOVE NUMBERED CONTRACT/ORDER IS MODIFIED TO REFLECT THE ADMINISTRATIVE CHANGES (such as changes in paying office, appropriation date, etc.) SET FORTH IN ITEM 14, PURSUANT TO THE AUTHORITY OF FAR 43.103(b).

	 
	C.   THIS SUPPLEMENTAL AGREEMENT IS ENTERED INTO PURSUANT TO AUTHORITY OF:

	 
	D.   OTHER (Specify type of modification and authority)

	E.  IMPORTANT:   Contractor   o  is not.   x  is required to sign this document and return            0    copies to the issuing office.

	14.  DESCRIPTION OF AMENDMENT/MODIFICATION (Organized by UCF section headings, including solicitation/contract subject matter where feasible.)

	Tax ID Number:   33-0903395
DUNS Number:   121785997
A.   The purpose of this modification is to incorporate the following changes into the contract.
1.   All references in the contract to the Alternative Contracting Officer’s Representative (COR) are hereby deleted and replaced with the following:

Alternate COR:

Melissa Stundick, Ph.D.
Continued ...

	Except as provided herein, all terms and conditions of the document referenced in Item 9A or 10A, as heretofore changed, remains unchanged and in full force and effect.

	15A.  NAME AND TITLE OF SIGNER (Type or print)
	 16A.  NAME AND TITLE OF CONTRACTING OFFICER (Type or print)

	 
	ETHAN J. MUELLER

	15B.  CONTRACTOR/OFFEROR
	15C.  DATE SIGNED
	16B.  UNITED STATES OF AMERICA
	16C.  DATE SIGNED

	      
       (Signature of person authorized to sign)
	 
	/s/ Ethan J. Mueller   
(Signature of Contracting Officer)
	5/6/14

	
									
	CONTINUATION SHEET
	REFERENCE NO. OF DOCUMENT BEING CONTINUED
HHSO100201100013C/0019
	PAGE   OF

	2
	2

	NAME OF OFFEROR OR CONTACTOR
CHIMERIX, INC. 1377270

	ITEM NO.
(A)
	SUPPLIES/SERVICES
(B)
	QUANTITY
(C)
	UNIT
(D)
	UNIT PRICE
(E)
	AMOUNT
(F)

	 
	Acting Branch Chief Broad Spectrum Antimicrobials 
Division of CBRN Countermeasures
Biomedical Advanced Research & Development Authority (BARDA)
Office of Secretary for Preparedness & Response (ASPR)
Department of Health and Human Services

Mailing Address:

330 Independence Avenue, S.W. Room 640 G
Washington, D.C. 20201
Office: 202-205-7479
Email: Melissa.Stundick@HHS.Gov

2. Additionally, all references to the Mailing Address for the Contracting
Officer’s Representative (COR) in the contract are hereby deleted and replaced with
the following:

330 Independence Avenue, S.W. Room 640 G
Washington, D.C. 20201
Office: ###-##-####
Email: Claiborne.Hughes@HHS.Gov

B. This is a unilateral, no cost administrative modification. The total amount, 
the scope and all other terms and conditions of Contract HHS0100201100013C 
remain unchanged.

Period of Performance: 02/16/2011 to 08/31/2014

	 
	 
	 
	 

NSN 7540-01-152-8067    OPTIONAL FORM 336 (4-86)
Sponsored by GSA 
FAR (48 CFR) 53.110

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00241-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00241-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00241-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00241-of-00352.parquet"}]]